ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "From Lab to Launch: Spinning out Biotech Innovation with RBL’s Dr. Paul Wotton"
Episode Synopsis
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, sits down with Paul Wotton, PhD, CEO of RBL LLC, a venture studio partially owned by Rice University.
RBL’s mission is to transform groundbreaking research from the Rice Biotech LaunchPad into successful biotech startups. The company provides end-to-end support for early-stage ventures, from financial and business development services to clinical trial design, talent acquisition and capital sourcing.
Dr. Wotton shares insights from his extensive leadership and entrepreneurship career, including his time as president and CEO of Ocata Therapeutics (acquired by Astellas), and discusses how RBL is bridging academia and industry to accelerate biotech innovation.
Dr. Wotton has expertise in strategic growth, business transactions and product development, and has served on the boards of Vericel, Cynata Therapeutics, Kytopen, Combined Therapeutics and co-founded Avenge Bio. He has been recognized as a “Top 100 Innovation CEO” by World Biz Magazine and won Ernst & Young’s NJ Life Sciences Entrepreneur of the Year award in 2014.
Tune in to learn how venture studio models like RBL are reshaping biotech commercialization and empowering the next generation of life science entrepreneurs.
For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media
Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured
RBL’s mission is to transform groundbreaking research from the Rice Biotech LaunchPad into successful biotech startups. The company provides end-to-end support for early-stage ventures, from financial and business development services to clinical trial design, talent acquisition and capital sourcing.
Dr. Wotton shares insights from his extensive leadership and entrepreneurship career, including his time as president and CEO of Ocata Therapeutics (acquired by Astellas), and discusses how RBL is bridging academia and industry to accelerate biotech innovation.
Dr. Wotton has expertise in strategic growth, business transactions and product development, and has served on the boards of Vericel, Cynata Therapeutics, Kytopen, Combined Therapeutics and co-founded Avenge Bio. He has been recognized as a “Top 100 Innovation CEO” by World Biz Magazine and won Ernst & Young’s NJ Life Sciences Entrepreneur of the Year award in 2014.
Tune in to learn how venture studio models like RBL are reshaping biotech commercialization and empowering the next generation of life science entrepreneurs.
For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media
Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured
More episodes of the podcast Xtalks Life Science Podcast
Exploring the Future of Cannabinoid & Psychedelic Therapies with Joel Latham of Incannex Healthcare
30/09/2025
Bridging Aesthetics and Therapeutics in Dermatology with Galderma’s Dr. Bill Andriopoulos
03/09/2025
Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong
19/08/2025
In God we trust